966. Deputy John Paul O'Shea asked the Minister for Health the current status of the reimbursement application for givinostat for the treatment of Duchenne muscular dystrophy; the timeline for consideration of the drug by the HSE Drugs Group and subsequent decision-making processes; the measures being taken to ensure that, should reimbursement be approved, access can be provided to eligible patients without unnecessary delay; and if she will make a statement on the matter. [45587/26]

Summary

966. Deputy John Paul O'Shea asked the Minister for Health the current status of the reimbursement application for givinostat for the treatment of Duchenne muscular dystrophy; the timeline for consideration of the drug by the HSE Drugs Group and subsequent decision-making processes; the measures being taken to ensure that, should reimbursement be approved, access can be provided to eligible patients without unnecessary delay; and if she will make a statement on the matter. [45587/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 16 June 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.